Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Gut. 2012 Sep;61(9):1279-83. doi: 10.1136/gutjnl-2011-301095. Epub 2011 Dec 19.
An association between endometriosis and certain autoimmune diseases has been suggested. However, the impact of endometriosis on risk of inflammatory bowel disease (IBD) remains unknown.
To assess the risk of Crohn's disease (CD) and ulcerative colitis (UC) in an unselected nationwide Danish cohort of women with endometriosis.
By use of national registers, 37 661 women hospitalised with endometriosis during 1977-2007 were identified. The relative risk of developing IBD after an endometriosis diagnosis was calculated as observed versus expected numbers and presented as standardised incidence ratios (SIRs) with 95% CIs.
Women with endometriosis had a increased risk of IBD overall (SIR=1.5; 95% CI 1.4 to 1.7) and of UC (SIR=1.5; 95% CI 1.3 to 1.7) and CD (SIR=1.6; 95% CI 1.3 to 2.0) separately, even 20 years after a diagnosis of endometriosis (UC: SIR=1.5; 95% CI 1.1 to 2.1; CD: SIR=1.8; 95% CI 1.1 to 3.2). Restricting analyses to women with surgically verified endometriosis suggested even stronger associations (UC: SIR=1.8; 95% CI 1.4 to 2.3; CD: SIR=1.7; 95% CI 1.2 to 2.5).
The risk of IBD in women with endometriosis was increased even in the long term, hence suggesting a genuine association between the diseases, which may either reflect common immunological features or an impact of endometriosis treatment with oral contraceptives on risk of IBD.
子宫内膜异位症与某些自身免疫性疾病之间存在关联。然而,子宫内膜异位症对炎症性肠病(IBD)风险的影响尚不清楚。
在丹麦全国范围内,对患有子宫内膜异位症的女性队列进行研究,评估其患克罗恩病(CD)和溃疡性结肠炎(UC)的风险。
利用国家登记册,确定了 1977 年至 2007 年间因子宫内膜异位症住院的 37661 名女性。通过观察到的病例数与预期病例数计算出子宫内膜异位症诊断后发生 IBD 的相对风险,并以标准化发病比(SIR)及其 95%置信区间(CI)表示。
患有子宫内膜异位症的女性总体上患 IBD 的风险增加(SIR=1.5;95%CI 1.4-1.7),UC(SIR=1.5;95%CI 1.3-1.7)和 CD(SIR=1.6;95%CI 1.3-2.0)的风险也增加,甚至在子宫内膜异位症诊断 20 年后也是如此(UC:SIR=1.5;95%CI 1.1-2.1;CD:SIR=1.8;95%CI 1.1-3.2)。将分析仅限于经手术证实患有子宫内膜异位症的女性,提示相关性更强(UC:SIR=1.8;95%CI 1.4-2.3;CD:SIR=1.7;95%CI 1.2-2.5)。
患有子宫内膜异位症的女性患 IBD 的风险即使在长期内也增加,这表明这两种疾病之间存在真正的关联,这可能反映了它们具有共同的免疫特征,也可能是子宫内膜异位症治疗(口服避孕药)对 IBD 风险的影响。